PTC Therapeutics
PTCT
$28.57
Share price
12.08%
Change (1 day)
-45.73%
Change (1 year)
Categories
PTC Therapeutics (PTCT) - Net assets
Net assets on the balance sheet as of December 2023 : -$0.82 B
According to PTC Therapeutics
's latest financial reports the company has -$0.82 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
PTC Therapeutics - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-0.82 B | 135.84% |
| 2022-12-31 | $-0.35 B | -24236.72% |
| 2021-12-31 | $1.43 M | -99.7% |
| 2020-12-31 | $0.48 B | -18.9% |
| 2019-12-31 | $0.59 B | 69.46% |
| 2018-12-31 | $0.35 B | 124.2% |
| 2017-12-31 | $0.15 B | 30.82% |
| 2016-12-31 | $0.11 B | -47.09% |
| 2015-12-31 | $0.22 B | -24.28% |
| 2014-12-31 | $0.29 B | 118.59% |
| 2013-12-31 | $0.13 B | -811.36% |
| 2012-12-31 | $-19.2 M | -91.96% |
| 2011-12-31 | $-0.24 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $39.75 B | -4,956.85% | 🇨🇭 Switzerland |
 Vertex Pharmaceuticals VRTX | $17.58 B | -2,247.74% | 🇺🇸 USA |
 Xencor XNCR | $0.66 B | -181.75% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $0.85 B | -204.98% | 🇺🇸 USA |
 Fate Therapeutics
FATE | $0.36 B | -145.01% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.50 B | -161.18% | 🇺🇸 USA |